Jamjoom Pharma and Mubadala Bio’s Bioventure Healthcare Partner to Enhance Ustekinumab Access in UAE
Abu Dhabi:Jamjoom Pharma, a prominent player in the regional pharmaceutical industry, has announced a partnership with Mubadala Bio’s subsidiary Bioventure Healthcare (BVH) to expand patient access to Ustekinumab in the United Arab Emirates.
Accordi…